In the last trading session, 3.23 million shares of the Ensysce Biosciences Inc (NASDAQ:ENSC) were traded, and its beta was 0.66. Most recently the company’s share price was $0.67, and it changed around $0.03 or 5.46% from the last close, which brings the market valuation of the company to $13.84M. ENSC currently trades at a discount to its 52-week high of $2.06, offering almost -207.46% off that amount. The share price’s 52-week low was $0.14, which indicates that the current value has risen by an impressive 79.1% since then. We note from Ensysce Biosciences Inc’s average daily trading volume that its 10-day average is 21.34 million shares, with the 3-month average coming to 27.52 million.
Ensysce Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ENSC as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Ensysce Biosciences Inc is expected to report earnings per share of -0.13 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ensysce Biosciences Inc (NASDAQ:ENSC) trade information
Instantly ENSC has showed a green trend with a performance of 5.46% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8100 on recent trading dayincreased the stock’s daily price by 17.28%. The company’s shares are currently down -36.75% year-to-date, but still down -8.16% over the last five days. On the other hand, Ensysce Biosciences Inc (NASDAQ:ENSC) is 273.90% up in the 30-day period. We can see from the shorts that 6.35 million shares have been sold at a short interest cover period of 0.12 day(s).
Ensysce Biosciences Inc (ENSC) estimates and forecasts
Ensysce Biosciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 7.44 percent over the past six months and at a 69.51% annual growth rate that is well above the industry average of 17.50%. The year-over-year growth rate is expected to be -59.65%, down from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 200k in revenue for the current quarter. The company’s sales for the same quarters a year ago were 515.03k and 305.72k respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -61.17%. Forecasts for the next quarter put sales growth at -100.00%.
ENSC Dividends
Ensysce Biosciences Inc’s next quarterly earnings report is expected to be released in December.
Ensysce Biosciences Inc (NASDAQ:ENSC)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.17% of Ensysce Biosciences Inc shares, and 22.26% of them are in the hands of institutional investors. The stock currently has a share float of 22.53%. Ensysce Biosciences Inc stock is held by 14.0 institutions, with PLANTE MORAN FINANCIAL ADVISORS, LLC being the largest institutional investor. By 2024-06-30, it held 0.0004% of the shares, which is about 20.0 shares worth $10.0.
